Milestone Advisory Partners’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
BCM
Milestone Advisory Partners's RGEN Position: Q1 2022 in Review
Milestone Advisory Partners sold out of Repligen (RGEN) in Q1 2022, closing a stake of 895 shares — an estimated $237K sold.
Milestone Advisory Partners first reported a position in RGEN in Q3 2021 and held it in 2 quarters. The position peaked at $259K in Q3 2021. 450 funds tracked by Wall St. Rank hold RGEN as of Q1 2022.
- Milestone Advisory Partners reported no remaining Repligen position as of Q1 2022 after selling out during the quarter.
- Milestone Advisory Partners sold 895 Repligen shares in Q1 2022, an estimated $237K.
- Milestone Advisory Partners first reported a position in Repligen in Q3 2021 and held it in 2 quarters.
- Milestone Advisory Partners's Repligen position peaked at $259K in Q3 2021.
- 450 funds tracked by Wall St. Rank held Repligen as of Q1 2022.
Based on Milestone Advisory Partners's 13F filing for Q1 2022, filed 10 May 2022.